Correlation Between Armata Pharmaceuticals and Fresh Tracks

Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Fresh Tracks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Fresh Tracks into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Armata Pharmaceuticals and Fresh Tracks Therapeutics, you can compare the effects of market volatilities on Armata Pharmaceuticals and Fresh Tracks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Fresh Tracks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Fresh Tracks.

Diversification Opportunities for Armata Pharmaceuticals and Fresh Tracks

0.0

Correlation Coefficient

Armata Pharmaceuticals  Fresh Tracks

Pay attention - limited upside

The 3 months correlation between Armata and Fresh is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Fresh Tracks Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fresh Tracks Therapeutics and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Fresh Tracks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fresh Tracks Therapeutics has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Fresh Tracks go up and down completely randomly.

Pair Corralation between Armata Pharmaceuticals and Fresh Tracks

If you would invest  198.00  in Armata Pharmaceuticals on December 19, 2024 and sell it today you would earn a total of  7.00  from holding Armata Pharmaceuticals or generate 3.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Armata Pharmaceuticals  vs.  Fresh Tracks Therapeutics

Armata Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Armata Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal primary indicators, Armata Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Fresh Tracks Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fresh Tracks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Fresh Tracks is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Armata Pharmaceuticals and Fresh Tracks

The main advantage of trading using opposite Armata Pharmaceuticals and Fresh Tracks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Fresh Tracks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresh Tracks will offset losses from the drop in Fresh Tracks' long position.

The idea behind Armata Pharmaceuticals and Fresh Tracks Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.